Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex.

Horner WE, Johnson DE, Schmidt AW, Rollema H.

Eur J Pharmacol. 2007 Mar 8;558(1-3):96-7. Epub 2006 Dec 1.

PMID:
17198700
2.

Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.

Liu LL, Yang J, Lei GF, Wang GJ, Wang YW, Sun RP.

Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):527-32. doi: 10.1111/j.1742-7843.2008.00230.x. Epub 2008 Mar 16.

3.

Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.

Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T.

J Neurochem. 2010 Jul;114(1):259-70. doi: 10.1111/j.1471-4159.2010.06750.x. Epub 2010 Apr 16.

4.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
5.

Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.

Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E.

Behav Brain Res. 2010 Jun 26;210(1):99-106. doi: 10.1016/j.bbr.2010.02.020. Epub 2010 Feb 13.

PMID:
20156489
6.

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW.

Neuropsychopharmacology. 2002 Nov;27(5):699-711.

7.
8.

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP.

Neuropharmacology. 2006 May;50(6):755-60. Epub 2006 Jan 19.

PMID:
16427661
9.

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.

Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG.

Mol Psychiatry. 2006 Feb;11(2):187-95.

PMID:
16231039
11.

Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.

Husarova V, Bittsansky M, Ondrejka I, Dobrota D.

Psychiatry Res. 2014 Apr 30;222(1-2):75-83. doi: 10.1016/j.pscychresns.2014.03.003. Epub 2014 Mar 15.

PMID:
24679996
12.
13.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
14.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
15.

Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.

Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, Rubia K.

Biol Psychiatry. 2013 Oct 15;74(8):615-22. doi: 10.1016/j.biopsych.2013.03.030. Epub 2013 May 31.

PMID:
23731741
16.

Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.

Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.

Psychol Med. 2014 Feb;44(3):633-46. doi: 10.1017/S0033291713000676. Epub 2013 Apr 19.

PMID:
23597077
17.

Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.

Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):34-41. Epub 2007 Jun 27.

PMID:
17714843
19.

Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.

Reichel CM, Linkugel JD, Bevins RA.

Exp Clin Psychopharmacol. 2007 Oct;15(5):501-9.

PMID:
17924784
20.

Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.

Ago Y, Umehara M, Higashino K, Hasebe S, Fujita K, Takuma K, Matsuda T.

Neurochem Res. 2014 May;39(5):825-32. doi: 10.1007/s11064-014-1275-5. Epub 2014 Mar 15.

PMID:
24634253

Supplemental Content

Support Center